Moleculin Receives UK MHRA Approval For Phase 1a Trail Of WP1122 To Treat Covid-19
Moleculin Biotech, Inc., a clinical stage pharmaceutical company along with a wide portfolio of the drug candidates targeting the highly resistant tumors and viruses announced that, it has now received the approval from the MHRA of the United Kingdom for proceeding with a first-in-human Phase 1a study for the purpose of evaluating the safety and […]
Continue Reading